How much would you pay for the tremor-reducing GyroGlove?

News

Author: Geoffrey ChangPublished: 7 October 2016

Prep: Cook: Serves:

Developments have been made on GyroGlove – the innovative tremor-reducing glove – and now the GyroGear team behind the technology are asking the Parkinson’s community to complete a survey on the pricing of their device. The survey takes five minutes to complete and is anonymous. Your views and insights from the survey will help inform the pricing of the glove.

“The data will allow us to push for the most reasonable price without compromising on quality. It will inform which components we choose, where we manufacture, and how we design in order to make the GyroGlove an affordable and useful purchase,” say the team. “This information is going to be pivotal in the coming months, as we finalise device specifications.”

This latest move suggests GyroGlove is in the final stages of development and that it won’t be long until the product hit the shelves.

The survey will be available until 12 October.

Last Month

Next Month

Go Back

Share this story

Comments

Susan Harris

Like any Parkinson’s person with tremors I would pay just about anything which is exactly what it will cost – no one will know the real cost as is the case with all pharmaceutical products. Before I recommend a price I would like to know more about the product and how much the cost is to make and market it.

Health & Fitness

Dance like Parkinson’s ain’t watching!

Discover the dance scheme that's moving patients worldwide

Sexuality and Parkinson’s: the needs of caregivers

Tips for maintaining couple intimacy in Parkinson’s

Run for Parkinson’s: campaigners raise £321,000 at London marathon

A snapshot of the campaigners who ran for Parkinson's

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Researchers have discovered that a molecule called BT13 could have potential to treat Parkinson’s. The study, conducted by scientists from the University of Helsinki, Finland, found that mice injected with the BT13 molecule had an increase in dopamine levels in the brain. Their findings also suggested that the molecule could lead to a new drug treatment to protect the brain cells that produce dopamine. Dopamine helps coordinate movement, but people with Parkinson’s have normally lost between 70 and 80% of the brain cells that produce the neurotransmitter when they are diagnosed with the condition. Professor David Dexter, Deputy Director of Research at Parkinson’s UK – which co-funded the study – said: “People with Parkinson’s desperately need a new treatment that can stop the condition in its tracks, instead of just masking the symptoms. “More research is needed to turn BT13 into a treatment to be tested in clinical trials, to…

Students develop wearable device to track Parkinson’s tremors

A wearable device has been developed to monitor Parkinson’s tremors and their severity through the tracking of body movements. The device – Tremor Tracker – was created by two students, Julie Gaudin and Elizabeth Hummel, at Louisiana Tech University, US, as part of a design class project. The students designed an algorithm using data recorded from volunteer participants at Rock Steady, a boxing programme for people with Parkinson’s. They then applied the algorithm to a GENEActiv, a wrist-worn device that has been scientifically validated for clinical research. Hummel, co-creator of the Tremor Tracker, said: “Through supervised machine learning, the device predicts whether a patient’s tremors are parkinsonian or non-parkinsonian, as well as the severity of these tremors. A quantitative analysis of parkinsonian tremors provides a more detailed disease state.”

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

Reawakening dormant neurons could help reverse Parkinson’s motor symptoms, researchers in South Korea have found. While Parkinson’s is typically believed to be caused by neuronal death, a new study – published in ‘Current Biology’ journal – suggests that dormant neurons could be another cause. After completing an animal test – which treated the subjects with two compounds that block dopamine-producing neurons from becoming dormant – the researchers found these neurons to be “awakened”, allowing them to resume dopamine production. The researchers hope that this will lead to a disease-modifying treatment, especially for people in the early stages of Parkinson’s. Hoon Ryu, a senior author of the study and researcher at KIST Brain Science Institute, South Korea, said: “This research refutes the common belief that there is no disease-modifying treatment for Parkinson’s due to its basis on neuronal cell death.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

How much would you pay for the tremor-reducing GyroGlove?

News

Author: Geoffrey ChangPublished: 7 October 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Health & Fitness

Dance like Parkinson’s ain’t watching!

Health & Fitness

Sexuality and Parkinson’s: the needs of caregivers

Europe

Run for Parkinson’s: campaigners raise £321,000 at London marathon

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Students develop wearable device to track Parkinson’s tremors

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

{title}

Subscribe

How much would you pay for the tremor-reducing GyroGlove?

News

Author: Geoffrey ChangPublished: 7 October 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Health & Fitness

Dance like Parkinson’s ain’t watching!

Health & Fitness

Sexuality and Parkinson’s: the needs of caregivers

Europe

Run for Parkinson’s: campaigners raise £321,000 at London marathon

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Students develop wearable device to track Parkinson’s tremors

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

{title}

Subscribe

Sign in